Bilal Bashir
Overview
Explore the profile of Bilal Bashir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loughrey P, Ayuk J, Bashir B, Higham C, Ho J, Monaghan P, et al.
Eur J Endocrinol
. 2025 Mar;
PMID: 40037929
No abstract available.
2.
Bashir B, Downie P, Forrester N, Wierzbicki A, Dawson C, Jones A, et al.
Arterioscler Thromb Vasc Biol
. 2024 Sep;
44(11):2334-2346.
PMID: 39234690
Background: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder. This study aimed to study the genotype distribution of FCS-causing genes in the United Kingdom, genotype-phenotype correlation, and clinical...
3.
Bashir B, Schofield J, Downie P, France M, Ashcroft D, Wright A, et al.
Front Cardiovasc Med
. 2024 Aug;
11:1389106.
PMID: 39171323
Aims: Historically, atherosclerotic cardiovascular disease (ASCVD) risk profile mitigation has had a predominant focus on low density lipoprotein cholesterol (LDL-C). In this narrative review we explore the residual ASCVD risk...
4.
Heald A, Mannan F, Wiltshire R, Ghaffari P, Waheed U, Zdravkovic D, et al.
Diabetes Ther
. 2024 Jul;
15(9):2097-2107.
PMID: 39078476
Introduction: Bariatric surgery (BS) has emerged an effective intervention in achieving significant and sustained weight loss in patients with type 2 diabetes (T2D). However, comprehensive data on the long-term impact...
5.
Bashir B, Ferdousi M, Durrington P, Soran H
Curr Opin Lipidol
. 2024 Jun;
35(4):208-218.
PMID: 38841827
Purpose Of Review: This review endeavours to explore the aetiopathogenesis and impact of severe hypertriglyceridemia (SHTG) and chylomicronaemia on cardiovascular, and pancreatic complications and summarizes the novel pharmacological options for...
6.
Pasha R, Bashir B, Omed D, Adam S, Kamath A, Elhofy A, et al.
Clin Ther
. 2024 May;
46(5):411-419.
PMID: 38744540
Purpose: There are inconsistent reports of an association between low cholesterol, use of lipid-lowering agents, and carcinogenesis. The purpose of this paper was to examine the relationship between cancer, lipids,...
7.
Bashir B, Kwok S, Wierzbicki A, Jones A, Dawson C, Downie P, et al.
Atherosclerosis
. 2024 Mar;
391:117476.
PMID: 38447437
Background And Aims: Prognosis and management differ between familial chylomicronaemia syndrome (FCS), a rare autosomal recessive disorder, and multifactorial chylomicronaemia syndrome (MCS) or severe mixed hyperlipidaemia. A clinical scoring tool...
8.
Heald A, Fachim H, Bashir B, Garside B, Adam S, Iqbal Z, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069302
Bariatric surgery improves dyslipidaemia and reduces body weight, but it remains unclear how bariatric surgery modulates gene expression in fat cells to influence the and gene expression. The expression of...
9.
Bashir B, Adam S, Ho J, Linn Z, Durrington P, Soran H
Curr Opin Lipidol
. 2023 Aug;
34(5):221-233.
PMID: 37560987
Purpose Of Review: The aim of this review was to provide an overview of the role of novel biomarkers in metabolic syndrome, their association with cardiovascular risk and the impact...
10.
Bashir B, Iqbal Z, Adam S, Ferdousi M, Chick W, Hussein H, et al.
Obes Rev
. 2023 Jul;
24(10):e13602.
PMID: 37515402
Bariatric surgery in people with obesity can lead to long-term remission of type 2 diabetes mellitus (T2DM) and a reduction in the incidence of macrovascular complications. The impact of bariatric...